Literature DB >> 18768877

Smallpox inhibitor of complement enzymes (SPICE): regulation of complement activation on cells and mechanism of its cellular attachment.

M Kathryn Liszewski1, Paula Bertram, Marilyn K Leung, Richard Hauhart, Lijuan Zhang, John P Atkinson.   

Abstract

Despite eradication of smallpox three decades ago, public health concerns remain due to its potential use as a bioterrorist weapon. Smallpox and other orthopoxviruses express virulence factors that inhibit the host's complement system. In this study, our goals were to characterize the ability of the smallpox inhibitor of complement enzymes, SPICE, to regulate human complement on the cell surface. We demonstrate that SPICE binds to a variety of cell types and that the heparan sulfate and chondroitin sulfate glycosaminoglycans serve as attachment sites. A transmembrane-engineered version as well as soluble recombinant SPICE inhibited complement activation at the C3 convertase step with equal or greater efficiency than that of the related host regulators. Moreover, SPICE attached to glycosaminoglycans was more efficient than transmembrane SPICE. We also demonstrate that this virulence activity of SPICE on cells could be blocked by a mAb to SPICE. These results provide insights related to the complement inhibitory activities of poxviral inhibitors of complement and describe a mAb with therapeutic potential.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18768877      PMCID: PMC2774262          DOI: 10.4049/jimmunol.181.6.4199

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  45 in total

Review 1.  Complement inhibitor C4b-binding protein-friend or foe in the innate immune system?

Authors:  Anna M Blom; Bruno O Villoutreix; Björn Dahlbäck
Journal:  Mol Immunol       Date:  2004-04       Impact factor: 4.407

2.  CHO glycosylation mutants: proteoglycans.

Authors:  Lijuan Zhang; Roger Lawrence; Beth A Frazier; Jeffrey D Esko
Journal:  Methods Enzymol       Date:  2006       Impact factor: 1.600

3.  Variola virus immune evasion design: expression of a highly efficient inhibitor of human complement.

Authors:  Ariella M Rosengard; Yu Liu; Zhiping Nie; Robert Jimenez
Journal:  Proc Natl Acad Sci U S A       Date:  2002-05-28       Impact factor: 11.205

4.  6-O-sulfotransferase-1 represents a critical enzyme in the anticoagulant heparan sulfate biosynthetic pathway.

Authors:  L Zhang; D L Beeler; R Lawrence; M Lech; J Liu; J C Davis; Z Shriver; R Sasisekharan; R D Rosenberg
Journal:  J Biol Chem       Date:  2001-09-10       Impact factor: 5.157

5.  Restoration of complement-enhanced neutralization of vaccinia virus virions by novel monoclonal antibodies raised against the vaccinia virus complement control protein.

Authors:  Stuart N Isaacs; Emelia Argyropoulos; Georgia Sfyroera; Shamim Mohammad; John D Lambris
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

6.  The detection of monkeypox in humans in the Western Hemisphere.

Authors:  Kurt D Reed; John W Melski; Mary Beth Graham; Russell L Regnery; Mark J Sotir; Mark V Wegner; James J Kazmierczak; Erik J Stratman; Yu Li; Janet A Fairley; Geoffrey R Swain; Victoria A Olson; Elizabeth K Sargent; Sue C Kehl; Michael A Frace; Richard Kline; Seth L Foldy; Jeffrey P Davis; Inger K Damon
Journal:  N Engl J Med       Date:  2004-01-22       Impact factor: 91.245

7.  Heparan sulfate 3-O-sulfotransferase isoform 5 generates both an antithrombin-binding site and an entry receptor for herpes simplex virus, type 1.

Authors:  Guoqing Xia; Jinghua Chen; Vaibhav Tiwari; Wujian Ju; Jin-Ping Li; Anders Malmstrom; Deepak Shukla; Jian Liu
Journal:  J Biol Chem       Date:  2002-07-23       Impact factor: 5.157

Review 8.  Human monkeypox: an emerging zoonosis.

Authors:  Daniel B Di Giulio; Paul B Eckburg
Journal:  Lancet Infect Dis       Date:  2004-01       Impact factor: 25.071

9.  Structure of vaccinia complement protein in complex with heparin and potential implications for complement regulation.

Authors:  Vannakambadi K Ganesh; Scott A Smith; Girish J Kotwal; Krishna H M Murthy
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-03       Impact factor: 11.205

10.  The biosynthesis of anticoagulant heparan sulfate by the heparan sulfate 3-O-sulfotransferase isoform 5.

Authors:  Michael B Duncan; Jinghua Chen; Jeffrey P Krise; Jian Liu
Journal:  Biochim Biophys Acta       Date:  2004-03-17
View more
  21 in total

Review 1.  The complement system in COVID-19: friend and foe?

Authors:  Anuja Java; Anthony J Apicelli; M Kathryn Liszewski; Ariella Coler-Reilly; John P Atkinson; Alfred Hj Kim; Hrishikesh S Kulkarni
Journal:  JCI Insight       Date:  2020-08-06

2.  Smallpox inhibitor of complement enzymes (SPICE): dissecting functional sites and abrogating activity.

Authors:  M Kathryn Liszewski; Marilyn K Leung; Richard Hauhart; Celia J Fang; Paula Bertram; John P Atkinson
Journal:  J Immunol       Date:  2009-08-10       Impact factor: 5.422

Review 3.  Therapeutic potential of complement modulation.

Authors:  Eric Wagner; Michael M Frank
Journal:  Nat Rev Drug Discov       Date:  2009-12-04       Impact factor: 84.694

Review 4.  Viral-derived complement inhibitors: current status and potential role in immunomodulation.

Authors:  Hadi Abou-El-Hassan; Hassan Zaraket
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-26

Review 5.  Interactions of viruses and the humoral innate immune response.

Authors:  Bailey E Maloney; Krishani Dinali Perera; Danielle R D Saunders; Naemi Shadipeni; Sherry D Fleming
Journal:  Clin Immunol       Date:  2020-02-04       Impact factor: 3.969

6.  Ectromelia virus inhibitor of complement enzymes protects intracellular mature virus and infected cells from mouse complement.

Authors:  Elizabeth A Moulton; Paula Bertram; Nanhai Chen; R Mark L Buller; John P Atkinson
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

7.  The Vaccinia virus complement control protein modulates adaptive immune responses during infection.

Authors:  Natasha M Girgis; Brian C Dehaven; Yuhong Xiao; Edward Alexander; Kendra M Viner; Stuart N Isaacs
Journal:  J Virol       Date:  2010-12-29       Impact factor: 5.103

8.  Species Specificity of Vaccinia Virus Complement Control Protein for the Bovine Classical Pathway Is Governed Primarily by Direct Interaction of Its Acidic Residues with Factor I.

Authors:  Jitendra Kumar; Viveka Nand Yadav; Swastik Phulera; Ashish Kamble; Avneesh Kumar Gautam; Hemendra Singh Panwar; Arvind Sahu
Journal:  J Virol       Date:  2017-09-12       Impact factor: 5.103

9.  Complement regulatory protein CD46 protects against choroidal neovascularization in mice.

Authors:  Valeriy Lyzogubov; Xiaobo Wu; Purushottam Jha; Ruslana Tytarenko; Michael Triebwasser; Grant Kolar; Paula Bertram; Puran S Bora; John P Atkinson; Nalini S Bora
Journal:  Am J Pathol       Date:  2014-07-11       Impact factor: 4.307

10.  Role of complement receptor 1 (CR1; CD35) on epithelial cells: A model for understanding complement-mediated damage in the kidney.

Authors:  Anuja Java; M Kathryn Liszewski; Dennis E Hourcade; Fan Zhang; John P Atkinson
Journal:  Mol Immunol       Date:  2015-08-07       Impact factor: 4.407

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.